Αποτελέσματα Αναζήτησης
Malignant ascites indicates the presence of malignant cells in the peritoneal cavity and is a grave prognostic sign. While survival in this patient population is poor, averaging about 20 wk from time of diagnosis, quality of life can be improved through palliative procedures.
- The Significance of Ascites in Patients With Pancreatic Ductal ...
In patients with pancreatic ductal adenocarcinoma (PDAC),...
- The Significance of Ascites in Patients With Pancreatic Ductal ...
Our findings also demonstrated that female gender is associated with longer survival and better prognosis in malignant ascites and we believe that this is due to the combined preponderance of ovarian and breast cancer groups.
For most patients, development of malignant ascites signals advanced, incurable cancer. Often, there may be no suitable cure for the underlying cancer. However, for some cancers (eg, ovarian cancer, lymphoma), treating the underlying cancer with chemotherapy and/or surgery may control ascites as well.
Malignant ascites affects a significant proportion of women with advanced and recurrent ovarian cancer. It frequently becomes the most pertinent issue in these patients and can have a detrimental effect on their QOL.
12 Σεπ 2023 · Ascites formation is a common complication of cancer with a significant symptomatic burden for patients. Malignant ascites (MA) is defined by the presence of tumor cells within the ascitic fluid. It does not only cause substantial morbidity, but is also associated with impaired survival.
In patients with pancreatic ductal adenocarcinoma (PDAC), ascites is often diagnosed late with average onset of 11 months from the time of diagnosis. Prognosis is poor after ascites development with an estimated median survival of 1.8 months from time of onset.
8 Μαΐ 2020 · The most important factor that influences patient prognosis in ovarian cancer is the resectability of the primary tumour and metastatic deposits—survival is optimal in cases where the cancer...
